阿尔兹海默病（Alzheimer's disease，AD）是一种慢性进行性神经退行性疾病，主要表现为记忆障碍、 认知功能下降及人格改变，占老年期痴呆病例的60%～80%。全球AD患者数量已超过5 000万，预计到 2050年将突破1.52亿，给患者家庭和社会带来沉重负担。AD的发病机制尚未完全阐明，现有药物虽可缓 解部分症状，但无法阻止疾病进展。本文对中药复方治疗AD的实验研究进展进行综述。

Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder characterized by memory impairment, cognitive decline, and personality changes, accounting for 60% to 80% of senile dementia cases. The global number of AD patients has exceeded 50 million and is projected to surpass 152 million by 2050, imposing a heavy burden on patients' families and society. The pathogenesis of AD remains incompletely understood, and while existing medications can alleviate some symptoms, they fail to halt disease progression. This article reviews experimental research advancements in TCM formulas for AD treatment.